Sleep as a biomarker for depression

International Review of Psychiatry

Volumn 25, Issue 5, 2013, Pages 632-645

  Wichniak, Adam ^a   Wierzbicka, Aleksandra ^a   Jernajczyk, Wojciech ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BIOLOGICAL MARKER; CITALOPRAM; CLOMIPRAMINE; CORTICOSTEROID; DESIPRAMINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PINDOLOL; REBOXETINE; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRIMIPRAMINE; VENLAFAXINE;

ARTICLE; DEPRESSION; DISEASE ASSOCIATION; DRUG MEGADOSE; ELECTROENCEPHALOGRAM; HUMAN; INSOMNIA; MULTIPLE SCLEROSIS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PSYCHOTHERAPY; RELAPSE; REM SLEEP; REMISSION; SLEEP DISORDER; SLEEP PARAMETERS;

BIOLOGICAL MARKERS; DEPRESSION; ELECTROENCEPHALOGRAPHY; HUMANS; SLEEP; SLEEP DISORDERS;

EID: 84886649543     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.3109/09540261.2013.812067     Document Type: Article

References (111)

1. Abad, V.C. & Guilleminault, C. (2005). Sleep and psychiatry. Dialogues in Clinical Neuroscience, 7, 291-303.
2. Achermann, P. & Borbely, A.A. (1987). Dynamics of EEG slow wave activity during physiological sleep and after administration of benzodiazepine hypnotics. Human Neurobiology, 6, 203-210.
3. Adrien, J. (2002). Neurobiological bases for the relation between sleep and depression. Sleep Medicine Reviews, 6, 341-351.
4. Ambrosius, U., Lietzenmaier, S., Wehrle, R., Wichniak, A., Kalus, S., Winkelmann, J., ? Friess, E. (2008). Heritability of sleep electroencephalogram . Biological Psychiatry, 64, 344-348.
5. Angst, J., Adolfsson, R., Benazzi, F., Gamma, A., Hantouche, E., Meyer, T. D., ? Scott, J. (2005). The HCL-32: Towards a self-assessment tool for hypomanic symptoms in outpatients. Journal of Affective Disorders, 88, 217-233.
6. Antonijevic, I.A. & Steiger, A. (2003). Depression-like changes of the sleep-EEG during high dose corticosteroid treatment in patients with multiple sclerosis. Psychoneuroendocrinology, 28, 780-795.
7. Argyropoulos, S.V. & Wilson, S.J. (2005). Sleep disturbances in depression and the effects of antidepressants. International Review of Psychiatry, 17, 237-245.
8. Armitage, R. (1995). Microarchitectural findings in sleep EEG in depression: Diagnostic implications. Biological Psychiatry, 37, 72-84.
9. Armitage, R. (2000). The effects of antidepressants on sleep in patients with depression. Canadian Journal of Psychiatry, 45, 803-809.
10. Armitage, R., Hoffmann, R.F. & Rush, A.J. (1999). Biological rhythm disturbance in depression: Temporal coherence of ultradian sleep EEG rhythms. Psychological Medicine, 29, 1435-1448.
11. Aserinsky, E. & Kleitman, N. (1953). Regularly occurring periods of eye motility, and concomitant phenomena during sleep. Science, 118, 273-274.
12. Baglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., ? Riemann, D. (2011). Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies. Journal of Affective Disorders, 135, 10-19.
13. Battaglia, M., Ferini, S.L., Bertella, S., Bajo, S. & Bellodi, L. (1999). First-cycle REM density in never-depressed subjects with borderline personality disorder. Biological Psychiatry, 45, 1056-1058.
14. Benca, R.M., Obermeyer, W.H., Thisted, R.A. & Gillin, J.C. (1992). Sleep and psychiatric disorders. A meta-analysis. Archives of General Psychiatry, 49, 651-668.
15. Benedetti, F. & Colombo, C. (2011). Sleep deprivation in mood disorders. Neuropsychobiology, 64, 141-151.
16. Borbely, A.A. (1982). A two process model of sleep regulation. Human Neurobiology, 1, 195-204.
17. Borbely, A.A. (1986). New techniques for the analysis of the human sleep-wake cycle. Brain and Development, 8, 482-488.
18. Borbely, A.A. (1987). The S-deficiency hypothesis of depression and the two-process model of sleep regulation. Pharmacopsychiatry , 20, 23-29.
19. Borbely, A.A. & Achermann, P. (1991). Ultradian dynamics of sleep after a single dose of benzodiazepine hypnotics. European Journal of Pharmacology, 195, 11-18.
20. Borbely, A.A., Mattmann, P., Loepfe, M., Strauch, I. & Lehmann, D. (1985). Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Human Neurobiology, 4, 189-194.
21. Brandenberger, G., Luthringer, R., Muller, G., Gronfier, C., Schaltenbrand, N., Macher, J.P., ? Follenius, M. (1996). 5-HT2 receptors are partially involved in the relationship between renin release and delta relative power. Journal of Endocrinological Investigation, 19, 556-562.
22. Brower, K.J., Hoffmann, R., Conroy, D.A., Arnedt, J.T. & Armitage, R. (2011). Sleep homeostasis in alcoholdependent, depressed and healthy control men. European Archives of Psychiatry and Clinical Neuroscience, 261, 559-566.
23. Buysse, D.J., Frank, E., Lowe, K.K., Cherry, C.R. & Kupfer, D.J. (1997). Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression. Biological Psychiatry, 41, 406-418.
24. Buysse, D.J., Hall, M., Begley, A., Cherry, C.R., Houck, P.R., Land, S., ? Frank, E. (2001). Sleep and treatment response in depression: New findings using power spectral analysis. Psychiatry Research, 103, 51-67.
25. Clark, C., Dupont, R., Golshan, S., Gillin, J.C., Rapaport, M.H. & Kelsoe, J.R. (2000). Preliminary evidence of an association between increased REM density and poor antidepressant response to partial sleep deprivation. Journal of Affective Disorders, 59, 77-83.
26. Clark, C.P., Gillin, J.C., Golshan, S., Demodena, A., Smith, T.L., Danowski, S., ? Schuckit, M. (1998). Increased REM sleep density at admission predicts relapse by three months in primary alcoholics with a lifetime diagnosis of secondary depression. Biological Psychiatry, 43, 601-607.
27. Datta, S., Patterson, E.H. & Spoley, E.E. (2001). Excitation of the pedunculopontine tegmental NMDA receptors induces wakefulness and cortical activation in the rat. Journal of Neuroscience Research, 66, 109-116.
28. de Bodinat, C., Guardiola-Lemaitre, B., Mocaer, E., Renard, P., Munoz, C. & Millan, M.J. (2010). Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nature Reviews Drug Discovery, 9, 628-642.
29. Dement, W. & Kleitman, N. (1957). Cyclic variations in EEG during sleep and their relation to eye movements, body motility, and dreaming. Electroencephalography and Clinical Neurophysiology, 9, 673-690.
30. Foster, F.G., Kupfer, D.J., Coble, P. & McPartland, R.J. (1976). Rapid eye movement sleep density. An objective indicator in severe medical-depressive syndromes. Archives of General Psychiatry, 33, 1119-1123.
31. Frank, E., Swartz, H.A. & Boland, E. (2007). Interpersonal and social rhythm therapy: An intervention addressing rhythm dysregulation in bipolar disorder. Dialogues in Clinical Neuroscience , 9, 325-332.
32. Friess, E., Modell, S., Brunner, H., Tagaya, H., Lauer, C.J., Holsboer, F. & Ising, M. (2008a). The Munich vulnerability study on affective disorders: Microstructure of sleep in highrisk subjects. European Archives of Psychiatry and Clinical Neuroscience, 258, 285-291.
33. Friess, E., Schmid, D., Modell, S., Brunner, H., Lauer, C.J., Holsboer, F. & Ising, M. (2008b). Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders. Journal of Psychiatric Research, 42, 1154-1162.
34. Germain, A. & Kupfer, D.J. (2008). Circadian rhythm disturbances in depression. Human Psychopharmacology: Clinical and Experimental, 23, 571-585.
35. Gillin, J.C., Duncan, W.C., Murphy, D.L., Post, R.M., Wehr, T.A., Goodwin, F.K., ? Bunney, W.E. (1981). Age-related changes in sleep in depressed and normal subjects . Psychiatry Research, 4, 73-78.
36. Gillin, J.C., Sutton, L., Ruiz, C., Kelsoe, J., Dupont, R.M., Darko, D., ? Janowsky, D. (1991). The cholinergic rapid eye movement induction test with arecoline in depression. Archives of General Psychiatry, 48, 264-270.
37. Goetz, R.R., Puig-Antich, J., Ryan, N., Rabinovich, H., Ambrosini, P.J., Nelson, B. & Krawiec, V. (1987). Electroencephalographic sleep of adolescents with major depression and normal controls. Archives of General Psychiatry, 44, 61-68.
38. Gorwood, P. (2007). Depression and circadian rhythm disturbances . Medicographia, 29, 22-27.
39. Gottschlich, M.M., Mayes, T., Khoury, J., McCall, J., Simakajornboon, N. & Kagan, R.J. (2011). The effect of ketamine administration on nocturnal sleep architecture. Journal of Burn Care and Research, 32, 535-540.
40. Hafner, S., Baumert, J., Emeny, R.T., Lacruz, M.E., Thorand, B., Herder, C., ? Ladwig, K.H. (2012). Sleep disturbances and depressed mood: A harmful combination associated with increased leptin levels in women with normal weight. Biological Psychology, 89, 163-169.
41. Hajak, G. & Landgrebe, M. (2010). Time and depression: When the internal clock does not work. Medicographia, 32, 146-151.
42. Held, K., Kunzel, H., Ising, M., Schmid, D.A., Zobel, A., Murck, H., ? Steiger, A. (2004). Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression. Journal of Psychiatric Research, 38, 129-136.
43. Hickie, I.B. & Rogers, N.L. (2011). Novel melatonin-based therapies: Potential advances in the treatment of major depression. Lancet, 378, 621-631.
44. Hirschfeld, R.M. (2002). The Mood Disorder Questionnaire: A simple, patient-rated screening instrument for bipolar disorder. Primary Care Companion to the Journal of Clinical Psychiatry, 4, 9-11.
45. Hobson, J.A., McCarley, R.W. & Wyzinski, P.W. (1975). Sleep cycle oscillation: Reciprocal discharge by two brainstem neuronal groups. Science, 189, 55-58.
46. Hoffmann, R., Hendrickse, W., Rush, A.J. & Armitage, R. (2000). Slow-wave activity during non-REM sleep in men with schizophrenia and major depressive disorders. Psychiatry Research, 95, 215-225.
47. Holsboer, F. (2000). The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology, 23, 477-501.
48. Hubain, P., Van, V.C., Staner, L., Mendlewicz, J. & Linkowski, P. (1996). Neuroendocrine and sleep variables in major dep ressed inpatients: Role of severity. Psychiatry Research, 63, 83-92.
49. Iovieno, N., van, N.A., Clain, A., Baer, L. & Nierenberg, A.A. (2011). Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse. Depression and Anxiety, 28, 137-144.
50. Janowsky, D.S., el-Yousef, M.K., Davis, J.M. & Sekerke, H.J. (1972). A cholinergic-adrenergic hypothesis of mania and depression. Lancet, 2, 632-635.
51. Jernajczyk, W. (1986). Latency of eye movement and other REM sleep parameters in bipolar depression. Biological Psychiatry, 21, 465-472.
52. Jindal, R.D., Fasiczka, A.L., Himmelhoch, J.M., Mallinger, A.G. & Thase, M.E. (2003). Effects of tranylcypromine on the sleep of patients with anergic bipolar depression. Psychopharmacology Bulletin, 37, 118-126.
53. Jindal, R.D. & Thase, M.E. (2004). Treatment of insomnia associated with clinical depression. Sleep Medicine Reviews, 8, 19-30.
54. Jindal, R.D., Thase, M.E., Fasiczka, A.L., Friedman, E.S., Buysse, D.J., Frank, E. & Kupfer, D.J. (2002). Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: II. Comparison during remission. Biological Psychiatry, 51, 230-236.
55. Jouvet, M. (1972). The role of monoamines and acetylcholinecontaining neurons in the regulation of the sleep-waking cycle. Ergebnisse der Physiologie, biologischen Chemie und experimentellen Pharmakologie, 64, 166-307.
56. Kaplan, K.A. & Harvey, A.G. (2009). Hypersomnia across mood disorders: A review and synthesis. Sleep Medicine Reviews, 13, 275-285.
57. Keshavan, M.S., Reynolds, C.F., Montrose, D., Miewald, J., Downs, C. & Sabo, E.M. (1994). Sleep and suicidality in psychotic patients. Acta Psychiatrica Scandinavica, 89, 122-125.
58. Kuenzel, H.E., Murck, H., Held, K., Ziegenbein, M. & Steiger, A. (2004). Reboxetine induces similar sleep-EEG changes like SSRIs in patients with depression. Pharmacopsychiatry, 37, 193-195.
59. Kupfer, D.J. (1976). REM latency: A psychobiologic marker for primary depressive disease. Biological Psychiatry, 11, 159-174.
60. Kupfer, D.J., Ehlers, C.L., Frank, E., Grochocinski, V.J. & McEachran, A.B. (1991). EEG sleep profiles and recurrent depression. Biological Psychiatry, 30, 641-655.
61. Kupfer, D.J., Ehlers, C.L., Frank, E., Grochocinski, V.J., McEachran, A.B. & Buhari, A. (1994). Persistent effects of antidepressants: EEG sleep studies in depressed patients during maintenance treatment. Biological Psychiatry, 35, 781-793.
62. Kupfer, D.J., Ehlers, C.L., Pollock, B.G., Nathan, R.S. & Perel, J.M. (1989). Clomipramine and EEG sleep in depression . Psychiatry Research, 30, 165-180.
63. Kupfer, D.J., Frank, E., McEachran, A.B. & Grochocinski, V.J. (1990). Delta sleep ratio. A biological correlate of early recurrence in unipolar affective disorder. Archives of General Psychiatry, 47, 1100-1105.
64. Landolt, H.P., Finelli, L.A., Roth, C., Buck, A., Achermann, P. & Borbely, A.A. (2000). Zolpidem and sleep deprivation: Different effect on EEG power spectra. Jorunal of Sleep Research, 9, 175-183.
65. Lauer, C.J., Riemann, D., Wiegand, M. & Berger, M. (1991). From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers. Biological Psychiatry, 29, 979-993.
66. Lauer, C.J., Schreiber, W., Holsboer, F. & Krieg, J.C. (1995). In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Archives of General Psychiatry, 52, 145-153.
67. Le Bon, O. (2005). Contribution of sleep research to the development of new antidepressants. Dialogues in Clinical Neuroscience, 7, 305-313.
68. Luthringer, R., Toussaint, M., Schaltenbrand, N., Bailey, P., Danjou, P.H., Hackett, D., ? Macher, J.P. (1996). A doubleblind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression. Psychopharmacology Bulletin, 32, 637-646.
69. McCarley, R.W. (1982). REM sleep and depression: Common neurobiological control mechanisms. American Journal of Psychiatry, 139, 565-570.
70. Modell, S., Huber, J., Holsboer, F. & Lauer, C.J. (2003). The Munich Vulnerability Study on Affective Disorders: Risk factors for unipolarity versus bipolarity. Journal of Affective Disorders, 74, 173-184.
71. Modell, S., Ising, M., Holsboer, F. & Lauer, C.J. (2002). The Munich Vulnerability Study on Affective Disorders: Stability of polysomnographic findings over time. Biological Psychiatry, 52, 430-437.
72. Modell, S., Ising, M., Holsboer, F. & Lauer, C.J. (2005). The Munich vulnerability study on affective disorders: Premorbid polysomnographic profile of affected high-risk probands. Biological Psychiatry, 58, 694-699.
73. Monteleone, P. & Maj, M. (2008). The circadian basis of mood disorders: Recent developments and treatment implications. European Neuropsychopharmacology, 18, 701-711.
74. Murck, H., Nickel, T., Kunzel, H., Antonijevic, I.A., Schill, J., Zobel, A., ? Holsboer, F. (2003). State markers of depression in sleep EEG: Dependency on drug and gender in patients treated with tianeptine or paroxetine. Neuropsychopharmacology , 28, 348-358.
75. Murray, G. (2007). Diurnal mood variation in depression: A signal of disturbed circadian function? Journal of Affective Disorders, 102, 47-53.
76. Nickel, T., Sonntag, A., Schill, J., Zobel, A.W., Ackl, N., Brunnauer, A., ? Holsboer, F. (2003). Clinical and neurobiological effects of tianeptine and paroxetine in major depression. Journal of Clinical Psychopharmacology, 23, 155-168.
77. Nissen, C., Feige, B., Konig, A., Voderholzer, U., Berger, M. & Riemann, D. (2001). Delta sleep ratio as a predictor of sleep deprivation response in major depression. Journal of Psychiatric Research, 35, 155-163.
78. Palagini, L., Baglioni, C., Ciapparelli, A., Gemignani, A. & Riemann, D. (2013). REM sleep dysregulation in depression: State of the art. Sleep Medicine Reviews. doi: 10.1016/j.smrv.2012.11.001.
79. Peeters, F., Berkhof, J., Delespaul, P., Rottenberg, J. & Nicolson, N.A. (2006). Diurnal mood variation in major depressive disorder. Emotion, 6, 383-391.
80. Pillai, V., Kalmbach, D.A. & Ciesla, J.A. (2011). A meta-analysis of electroencephalographic sleep in depression: Evidence for genetic biomarkers. Biological Psychiatry, 70, 912-919.
81. Puig-Antich, J., Goetz, R., Hanlon, C., Davies, M., Thompson, J., Chambers, W.J., ? Weitzman, E.D. (1982). Sleep architecture and REM sleep measures in prepubertal children with major depression: A controlled study. Archives of General Psychiatry, 39, 932-939.
82. Quera Salva, M.A., Hartley, S., Barbot, F., Alvarez, J.C., Lofaso, F. & Guilleminault, C. (2011). Circadian rhythms, melatonin and depression. Current Pharmaceutical Design, 17, 1459-1470.
83. Quera-Salva, M.A., Lemoine, P. & Guilleminault, C. (2010). Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients. Human Psychopharmacology: Clinical and Experimental, 25, 222-229.
84. Rao, U. & Poland, R.E. (2008). Electroencephalographic sleep and hypothalamic-pituitary-adrenal changes from episode to recovery in depressed adolescents. Journal of Child and Adolescent Psychopharmacology, 18, 607-613.
85. Richardson, G.S. (2005). The human circadian system in normal and disordered sleep. Journal of Clinical Psychiatry, 66 (S9), S3-9.
86. Riemann, D. & Berger, M. (1992). Sleep, age, depression and the cholinergic REM induction test with RS 86. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 16, 311-316.
87. Rodenbeck, A., Cohrs, S., Jordan, W., Huether, G., Ruther, E. & Hajak, G. (2003). The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks. Psychopharmacology (Berlin), 170, 423-428.
88. Roschke, J., Kogel, P., Schlosser, R., Wagner, P., Mann, K., Rossbach, W. & Benkert, O. (1997). Analysis of sleep EEG microstructure in subchronic paroxetine treatment of healthy subjects. Psychopharmacology (Berlin), 132, 44-49.
89. Rush, A.J., Erman, M.K., Giles, D.E., Schlesser, M.A., Carpenter, G., Vasavada, N. & Roffwarg, H.P. (1986). Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Archives of General Psychiatry, 43, 878-884.
90. Saletu-Zyhlarz, G.M., Abu-Bakr, M.H., Anderer, P., Gruber, G., Mandl, M., Strobl, R., ? Saletu, B. (2002). Insomnia in depression: Differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26, 249-260.
91. Salvadore, G. & Singh, J.B. (2013). Ketamine as a fast acting antidepressant: Current knowledge and open questions. CNS Neuroscience and Therapeutics.
92. Saper, C.B., Scammell, T.E. & Lu, J. (2005). Hypothalamic regulation of sleep and circadian rhythms. Nature, 437, 1257-1263.
93. Schlosser, R., Roschke, J., Rossbach, W. & Benkert, O. (1998). Conventional and spectral power analysis of all-night sleep EEG after subchronic treatment with paroxetine in healthy male volunteers. European Neuropsychopharmacology, 8, 273-278.
94. Schmid, D.A., Wichniak, A., Uhr, M., Ising, M., Brunner, H., Held, K., ? Steiger, A. (2006). Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine. Neuropsychopharmacology , 31, 832-844.
95. Schreiber, W., Lauer, C.J., Krumrey, K., Holsboer, F. & Krieg, J.C. (1992). Cholinergic REM sleep induction test in subjects at high risk for psychiatric disorders. Biological Psychiatry, 32, 79-90.
96. Sculthorpe, L.D. & Douglass, A.B. (2010). Sleep pathologies in depression and the clinical utility of polysomnography. Canadian Journal of Psychiatry, 55, 413-421.
97. Silber, M.H., Ancoli-Israel, S., Bonnet, M.H., Chokroverty, S., Grigg-Damberger, M.M., Hirshkowitz, M., ? Iber, C. (2007). The visual scoring of sleep in adults. Journal of Clinical Sleep Medicine, 3, 121-131.
98. Steiger, A. (2002). Sleep and the hypothalamo-pituitary-adrenocortical system. Sleep Medicine Reviews, 6, 125-138.
99. Steiger, A. & Kimura, M. (2010). Wake and sleep EEG provide biomarkers in depression. Journal of Psychiatric Research, 44, 242-252.
100. Taub, J.M., Hawkins, D.R. & van de Castle, R.L. (1978). Electrographic analysis of the sleep cycle in young depressed patients. Biological Psychology, 7, 203-214.
101. Thase, M.E., Buysse, D.J., Frank, E., Cherry, C.R., Cornes, C.L., Mallinger, A.G. & Kupfer, D.J. (1997). Which depressed patients will respond to interpersonal psychotherapy? The role of abnormal EEG sleep profiles. American Journal of Psychiatry, 154, 502-509.
102. Trachsel, L., Dijk, D.J., Brunner, D.P., Klene, C. & Borbely, A.A. (1990). Effect of zopiclone and midazolam on sleep and EEG spectra in a phase-advanced sleep schedule. Neuropsychopharmacology , 3, 11-18.
103. Van Bemmel, A.L., Beersma, D.G. & Van den Hoofdakker, R.H. (1995). Changes in EEG power density of non-REM sleep in depressed patients during treatment with trazodone. Journal of Affective Disorders, 35, 11-19.
104. Voderholzer, U. (2003). Sleep deprivation and antidepressant treatment. Dialogues in Clinical Neuroscience, 5, 366-369.
105. Vogel, G.W., Buffenstein, A., Minter, K. & Hennessey, A. (1990). Drug effects on REM sleep and on endogenous depression. Neuroscience and Biobehavioral Reviews, 14, 49-63.
106. Wichniak, A., Antczak, J., Wierzbicka, A. & Jernajczyk, W. (2002). Alterations in pattern of rapid eye movement activity during REM sleep in depression. Acta Neurobiologiae Experimentalis, 62, 243-250.
107. Wichniak, A., Brunner, H., Ising, M., Pedrosa, G.F., Holsboer, F. & Friess, E. (2004). Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression. Psychoneuroendocrinology, 29, 1101-1108.
108. Wichniak, A., Riemann, D., Kiemen, A., Voderholzer, U. & Jernajczyk, W. (2000). Comparison between eye movement latency and REM sleep parameters in major depression. European Archives of Psychiatry and Clinical Neuroscience, 250, 48-52.
109. Wichniak, A., Wierzbicka, A. & Jernajczyk, W. (2012). Sleep and antidepressant treatment. Current Pharmaceutical Design, 18, 5802-5817.
110. Wilson, S. & Argyropoulos, S. (2005). Antidepressants and sleep: A qualitative review of the literature. Drugs, 65, 927-947.
111. Wirz-Justice, A. & van den Hoofdakker, R.H. (1999). Sleep deprivation in depression: What do we know, where do we go? Biological Psychiatry, 46, 445-453.